Effect of Aerobic Exercise Associated With Abdominal Laser Therapy
Metabolic Disease
About this trial
This is an interventional prevention trial for Metabolic Disease focused on measuring Aerobic Exercise, Lipolytic Laser, Lipid Profile, C-reactive protein, Lipolysis
Eligibility Criteria
Inclusion Criteria:
- age between 18 and 25 years.
- BMI between 18,5Kg/m2 and 29,9Kg/m2
- consider presenting abdominal fat
Exclusion Criteria:
- pregnant or intending to be in a period of 9 months
- participants with smoking habits
- participants with neoplasias, metabolic dysfunctions, renal pathologies, dermatological alterations
- participants with electronic devices
- participants with a condition that makes it impossible to practice physical exercise (disabling skeletal muscle pathologies and severe cardiorespiratory pathologies)
- participants under the effect of beta-blockers or other drugs which influence heart rate
- participants submitted to other fat reduce procedure
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
Experimental group 1
Experimental group 2
Placebo group
This group performed aerobic exercise just after low level laser therapy in the abdominal region with eight electrodes distributed in line.
This group performed aerobic exercise just after low level laser therapy in the abdominal region with eight electrodes distributed in line, but low level laser therapy device was switched off.
Low level laser therapy without power. This group performed the low level laser therapy protocol, but low level laser therapy device was switched off.